SWISS RELIEF DUAL RELEASE

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
31-12-2023
Valmisteyhteenveto Valmisteyhteenveto (SPC)
27-12-2023

Aktiivinen ainesosa:

DICLOFENAC SODIUM

Saatavilla:

PADAGIS ISRAEL AGENCIES LTD, ISRAEL

ATC-koodi:

S01BC03

Lääkemuoto:

CAPSULES

Koostumus:

DICLOFENAC SODIUM 75 MG

Antoreitti:

PER OS

Prescription tyyppi:

Required

Valmistaja:

SWISS CAPS GMBH, GERMANY

Terapeuttinen ryhmä:

DICLOFENAC

Terapeuttinen alue:

DICLOFENAC

Käyttöaiheet:

As a non-steroidal anti-inflamatory analgesic in symptomatic management of rheumatoid arthritis osteoarthritis and ankylosying spondylitis acute musculo-skeletal disorders such as periarthritis tendenitis tensynovitis bursitis sprains strains and dislocations relief of pain in fractures low back pain acute gout psoriatic arthropathy. In the management of pain and inflammation associated with orthopaedic dental and minor surgery.

Valtuutus päivämäärä:

2014-11-30

Valmisteyhteenveto

                                SUMMARY OF PRODUCT CHARACTERISTICS
Swiss Relief Dual Release, 75 mg capsules
1. NAME OF THE MEDICINAL PRODUCT
Swiss Relief Dual Release
75 mg capsule
Diclofenac sodium
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule, hard, contains 75 mg diclofenac sodium (25 mg diclofenac
sodium in gastro-resistant form, 50 mg
diclofenac sodium in prolonged-release form).
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Capsules, hard.
Size 2 hard gelatine capsule with light blue cap and transparent body.
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
As a non-steroidal anti-inflammatory analgesic in symptomatic
management of rheumatoid arthritis, osteoarthritis
and ankylosying spondylitis, acute musculo-skeletal disorders such as
periarthritis, tendinitis, tensynovitis, bursitis,
sprains, strains and dislocations, relief of pain in fractures, low
back pain, acute gout, psoriatic arthropathy.
In the management of pain and inflammation associated with
orthopaedic, dental and minor surgery.
4.2 Posology and method of administration
Posology:
Diclofenac is dosed in relation to the severity of the condition. The
recommended dose range for adults is
between 50 and 150 mg diclofenac sodium per day.
Age:
Single dose:
Number of Swiss Relief Dual Release
capsules
Total daily dose:
Number of Swiss Relief Dual Release
capsules
Adults
1
(equivalent to 75 mg diclofenac sodium)
2
(equivalent to 150 mg diclofenac sodium)
Method of administration and duration of use:
Swiss Relief Dual Release is swallowed whole (without chewing) and
with plenty of liquid.
Those with sensitive stomachs are recommended to take Swiss Relief
Dual Release during meals.
The duration of use is decided by the treating physician.
For rheumatic diseases, it may be necessary to take Swiss Relief Dual
Release over a prolonged period of time.
Undesirable effects can be minimised if the lowest effective dose
required to achieve symptomatic control is used over
the shortest possible period of time (see section 4.4 Special warnings
and preca
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste arabia 31-12-2023
Pakkausseloste Pakkausseloste heprea 27-12-2023

Etsi tähän tuotteeseen liittyviä ilmoituksia